Physician profile
Neda Ashourian
NPI 1922212539
$2,426.99
in general payments reported to CMS, 2019-2025
22 companies · $348 in 2025
The $348 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $79.04 · 2021: $119 · 2022: $428 · 2023: $654 · 2024: $431 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,433.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $502.52 | 2022-2025 | Libtayo |
| Amgen INC. | $400.88 | 2022-2023 | Otezla |
| Almirall LLC | $271.34 | 2021-2025 | Klisyri |
| Biofrontera INC. | $230.63 | 2020-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Horizon Therapeutics Plc | $120.08 | 2022 | |
| Pfizer INC. | $112.94 | 2019-2022 | |
| Galderma Laboratories, L.P. | $100.51 | 2019-2020 | |
| Genentech USA, INC. | $94.50 | 2019-2021 | |
| Organogenesis INC. | $91.38 | 2022-2023 | Puraply |
| Genzyme Corporation | $81.96 | 2024 | |
| Sun Pharmaceutical Industries INC. | $77.10 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $51.84 | 2019-2023 | |
| Dusa Pharmaceuticals, INC. | $43.17 | 2019 | |
| Leo Pharma INC. | $41.57 | 2019 | |
| Ucb, INC. | $39.06 | 2024 | Bimzelx |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biowound Solutions, INC. | $33.04 | 2025 | Bio-Connekt |
| Helsinn Therapeutics (U.S.), INC. | $32.37 | 2024 | Valchlor |
| Novum Pharma, LLC | $23.69 | 2019 | |
| Aclaris Therapeutics, INC. | $22.49 | 2019 | |
| Celgene Corporation | $21.83 | 2019 | |
| Dermira, INC. | $21.79 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neda Ashourian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.